Product
FE 999302
Aliases
Choriogonadotropin beta
2 clinical trials
2 indications
Indication
Controlled Ovarian StimulationIndication
infertilityClinical trial
A Randomised, Double-blind, Placebo-controlled, Parallel-group, Dose-range Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation in a Long GnRH Agonist ProtocolStatus: Completed, Estimated PCD: 2019-10-21
Clinical trial
A Randomised, Assessor-blind, Active-controlled, Parallel-group, Dose-finding Trial to Investigate the Efficacy and Safety of FE 999302 for Triggering of Final Follicular Maturation in Women Undergoing Controlled Ovarian StimulationStatus: Withdrawn, Estimated PCD: 2024-03-25